Renal-Protective Drugs in Chronic Kidney Disease (CKD)

Created using ChatSlide

This presentation explores renal protection strategies in chronic kidney disease (CKD), emphasizing the comparative benefits of SGLT2 inhibitors, GLP-1 receptor agonists, and mineralocorticoid receptor antagonists. It highlights the dual kidney-cardiac risk prevalent in the UK and the importance of treating both simultaneously. Key studies, including BARACK-D and EMPA-KIDNEY, are analyzed for their outcomes and implications for clinical practice. Attendees will learn to tailor therapies based...